Molecular machine may lead to new drugs to combat human diseases
Scientists at Purdue University have made a breakthrough in understanding the molecular mechanism of Group I introns, which could lead to new treatments for human diseases. By crystallizing an intron at mid-point in its work cycle, researchers gained insights into how it binds with molecules and carries out biochemical reactions.